Company Filing History:
1 out of 3 
1 out of 832,912 Years Active: 2016
Title: The Innovative Mind of Jeffrey D. Endres
Introduction
Jeffrey D. Endres, an accomplished inventor based in La Mesa, California, has made notable contributions in the field of ophthalmic technology. With a total of two patents to his name, Endres has developed cutting-edge methods that improve the processing of polymeric substrates used in optical applications.
Latest Patents
Endres' latest patents include the "Particle-plasma ablation process for polymeric ophthalmic substrate surface" and the "Particle-plasma ablation process." Both patents describe innovative methods for simultaneously ablating and functionalizing surfaces. The intricate process involves applying a CO2 particle spray against an unreacted portion of the substrate surface, while simultaneously projecting ionizing-heating radiation into the spray. This unique combination creates an instantaneous surface treatment, enabling precise alterations to the substrate surface and facilitating the removal of reacted portions effectively.
Career Highlights
Throughout his career, Endres has worked with various organizations, including Cleanlogix LLC, a company known for its contributions to clean technology solutions. His work in these settings has allowed him to refine his inventive processes and bring valuable advancements to the market.
Collaborations
Endres has collaborated with notable professionals in his field, including coworker David P. Jackson. Such partnerships have undoubtedly enriched his research and development experience, leading to substantial contributions in the realm of polymeric substrate processing technologies.
Conclusion
Jeffrey D. Endres continues to be a significant figure in the innovation landscape of ophthalmic technology. His inventive methods and collaborative spirit exemplify the drive for excellence that inspires future developments in his field. With two patents that reflect his technical expertise and creative thinking, Endres stands out as a promising inventor ready to shape the future of polymeric ophthalmic applications.